Publications by authors named "Rosa Lerose"

Claim this Profile
M
Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approach.
Domiziana Masci, Michela Puxeddu, Claudia Colla, Antonio Coluccia, Martina Santelli, Rosa Lerose

RSC Med Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide and Etoposide: A mathematical evaluation of the decay of two highly reactive molecules.
Cristina Filosa, Nicola Antonio Colabufo, Marcello Leopoldo, Donatella Telesca, Maria Rita Milella, Rosa Lerose

J Oncol Pharm Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications.
Rosalia Dieli, Rosa Lioy, Fabiana Crispo, Nicoletta Cascelli, Mara Martinelli, Rosa Lerose

Biomolecules· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("" Study).
Alessandro Cafaro, Flavia Foca, Oriana Nanni, Marco Chiumente, Marina Coppola, Rosa Lerose

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL).
Alessandro Cafaro, Flavia Foca, Oriana Nanni, Marco Chiumente, Marina Coppola, Rosa Lerose

Front Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological evaluation of [4-(4-aminophenyl)-1-(4-fluorophenyl)-1H-pyrrol-3-yl](3,4,5-trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models.
Carmela Mazzoccoli, Fabiana Crispo, Ilaria Laurenzana, Michele Pietrafesa, Lorenza Sisinni, Rosa Lerose

Arch Pharm (Weinheim)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Treatment Approaches for Thymic Epithelial Tumors.
Alfredo Tartarone, Rosa Lerose, Alessandro Rocco Lettini, Marina Tartarone

Life (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Role of Tumor-Derived Exosomes in Non-Small-Cell Lung Cancer in the Era of Immunotherapy.
Alfredo Tartarone, Rosa Lerose, Marina Tartarone, Michele Aieta

Life (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decisions and dilemmas in non-metastatic castration-resistant prostate cancer management.
Alfredo Tartarone, Rosa Lerose, Marina Tartarone

Med Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of oligoprogression in non-small cell lung cancer patients.
Alfredo Tartarone, Rosa Lerose, Marina Tartarone

Med Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and cancer care: what do international guidelines say?
Alfredo Tartarone, Rosa Lerose

Med Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focus on lung cancer screening.
Alfredo Tartarone, Rosa Lerose, Michele Aieta

J Thorac Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk of smoking and benefits of smoking cessation.
Giuseppina Gallucci, Alfredo Tartarone, Rosa Lerose, Anna Vittoria Lalinga, Alba Maria Capobianco

J Thorac Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis.
Alfredo Tartarone, Giandomenico Roviello, Rosa Lerose, Raheleh Roudi, Michele Aieta

Future Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a role for immunotherapy in malignant pleural mesothelioma?
Alfredo Tartarone, Rosa Lerose, Michele Aieta

Med Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer.
Alfredo Tartarone, Rosa Lerose, Maria Grazia Rodriquenz, Giuseppina Mambella, Giuseppe Calderoni

J Thorac Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress and challenges in the treatment of small cell lung cancer.
Alfredo Tartarone, Pasqualina Giordano, Rosa Lerose, Maria Grazia Rodriquenz, Raffaele Conca

Med Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible applications of circulating tumor cells in patients with non small cell lung cancer.
Alfredo Tartarone, Elisabetta Rossi, Rosa Lerose, Giuseppina Mambella, Giuseppe Calderone

Lung Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring and Characterization of Circulating Tumor Cells (CTCs) in a Patient With EML4-ALK-Positive Non-Small Cell Lung Cancer (NSCLC).
Michele Aieta, Antonella Facchinetti, Stefania De Faveri, Mariangela Manicone, Alfredo Tartarone, Rosa Lerose

Clin Lung Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crizotinib-induced cardiotoxicity: the importance of a proactive monitoring and management.
Alfredo Tartarone, Giuseppina Gallucci, Chiara Lazzari, Rosa Lerose, Lucia Lombardi

Future Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatostatin Analog Therapy in Small Cell Lung Cancer.
Alfredo Tartarone, Rosa Lerose, Michele Aieta

Semin Nucl Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients.
Roberto Guariglia, Maria Carmen Martorelli, Rosa Lerose, Donatella Telesca, Maria Rita Milella

Biologics· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance.
Alfredo Tartarone, Rosa Lerose

Ther Adv Respir Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which tyrosine kinase inhibitor should be recommended as initial treatment for non-small cell lung cancer patients with EGFR mutations?
Alfredo Tartarone, Rosa Lerose, Chiara Lazzari, Vanesa Gregorc, Michele Aieta

Med Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival in small cell lung cancer: a case report and review of the literature.
Alfredo Tartarone, Rosa Lerose, Raffaele Ardito, Laura Troiani, Beatrice Tedesco

Future Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis